People are not rats
Much of the BPC-157 healing research involves rats and other lab work.
Those results do not establish that the same benefit happens in people.
When someone cites a study, ask which species was studied and which health problem was tested.
The human reports leave large gaps
The Food and Drug Administration (FDA) is the US agency that carries out medicine reviews. FDA’s review, recorded September 28, 2026, found five human studies with roughly eighty people given BPC-157 in total.
Only two used a comparison group. Both were reported in short summaries for medical meetings, rather than full reports describing the methods and results. A comparison group helps test whether a change is due to the treatment rather than something else.
The knee-pain report used neither a comparison group nor a standard measure of improvement. It cannot establish that BPC-157 caused people to feel better.
The bowel trial did not settle the question
The short trial used an enema: liquid placed in the last part of the bowel. It tested a bowel disease called ulcerative colitis.
FDA judged the reported data insufficient to establish benefit or safety for that use. That is a limit of the evidence, not proof that it cannot work.
A registered trial is a plan, not a result
On September 28, 2026, a trial for hamstring injuries in China was recruiting and had no results.
Ask for the result itself, not just a study registration or an account of what researchers hope to find.